101 related articles for article (PubMed ID: 28729202)
1. High proportion of modern genotypes of M. tuberculosis and their affinity with drug resistance in northern region of India.
Dhatwalia SK; Yadav R; Behera D; Kaur H; Kumar M; Sethi S
J Glob Antimicrob Resist; 2017 Sep; 10():84-87. PubMed ID: 28729202
[TBL] [Abstract][Full Text] [Related]
2. Distribution and association of Mycobacterium tuberculosis CAS lineage with multidrug resistance in North India.
Dhatwalia SK; Yadav R; Behera D; Rudramurthy SM; Kaur H; Sethi S
Int J Tuberc Lung Dis; 2016 Jun; 20(6):806-11. PubMed ID: 27155185
[TBL] [Abstract][Full Text] [Related]
3. Genotyping and molecular characteristics of multidrug-resistant Mycobacterium tuberculosis isolates from China.
Zhang Z; Lu J; Liu M; Wang Y; Qu G; Li H; Wang J; Pang Y; Liu C; Zhao Y
J Infect; 2015 Apr; 70(4):335-45. PubMed ID: 25485999
[TBL] [Abstract][Full Text] [Related]
4. Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil.
Esteves LS; Dalla Costa ER; Vasconcellos SEG; Vargas A; Ferreira Junior SLM; Halon ML; Ribeiro MO; Rodenbusch R; Gomes HM; Suffys PN; Rossetti MLR
Tuberculosis (Edinb); 2018 May; 110():36-43. PubMed ID: 29779771
[TBL] [Abstract][Full Text] [Related]
5. [Study on the prevalence of Beijing genotype Mycobacterium tuberculosis and its relationship with second-line anti-tuberculosis drug resistance].
Liang C; Zhang XX; Xing Q; Yi JL; Zhang YQ; Li CY; Liu Y; Tang SJ
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Apr; 43(4):356-361. PubMed ID: 32294818
[No Abstract] [Full Text] [Related]
6. Genotyping and drug resistance patterns of M. tuberculosis strains in Pakistan.
Tanveer M; Hasan Z; Siddiqui AR; Ali A; Kanji A; Ghebremicheal S; Hasan R
BMC Infect Dis; 2008 Dec; 8():171. PubMed ID: 19108722
[TBL] [Abstract][Full Text] [Related]
7. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.
Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y
Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458
[TBL] [Abstract][Full Text] [Related]
8. Genetic diversity of multidrug-resistant Mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran using MIRU-VNTR technique.
Khosravi AD; Shahraki AH; Dezfuli SK; Hashemzadeh M; Goodarzi H; Mohajeri P
Kaohsiung J Med Sci; 2017 Nov; 33(11):550-557. PubMed ID: 29050672
[TBL] [Abstract][Full Text] [Related]
9. Real-time PCR followed by high-resolution melting curve analysis: A rapid and pragmatic approach for screening of multidrug-resistant extrapulmonary tuberculosis.
Sharma K; Sharma M; Singh S; Modi M; Sharma A; Ray P; Varma S
Tuberculosis (Edinb); 2017 Sep; 106():56-61. PubMed ID: 28802406
[TBL] [Abstract][Full Text] [Related]
10. [GenoType MTBDR plus 1.0® for the detection of cross-resistance between isoniazide and ethionamide in isolates of multidrug-resistant Mycobacterium tuberculosis].
Rueda J; Realpe T; Mejía G; Zapata E; Robledo J
Biomedica; 2015; 35(4):541-8. PubMed ID: 26844443
[TBL] [Abstract][Full Text] [Related]
11. [Population structure analysis of Mycobacterium tuberculosis Beijing family in Japan].
Iwamoto T
Kekkaku; 2009 Dec; 84(12):755-9. PubMed ID: 20077859
[TBL] [Abstract][Full Text] [Related]
12. Multidrug-Resistant Mycobacterium tuberculosis of the Latin American Mediterranean Lineage, Wrongly Identified as Mycobacterium pinnipedii (Spoligotype International Type 863 [SIT863]), Causing Active Tuberculosis in South Brazil.
Dalla Costa ER; Vasconcelos SE; Esteves LS; Gomes HM; Gomes LL; da Silva PA; Perdigão J; Portugal I; Viveiros M; McNerney R; Pain A; Clark TG; Rastogi N; Unis G; Rossetti ML; Suffys PN
J Clin Microbiol; 2015 Dec; 53(12):3805-11. PubMed ID: 26400784
[TBL] [Abstract][Full Text] [Related]
13. Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India.
Maurya AK; Kant S; Nag VL; Kushwaha RA; Dhole TN
J Postgrad Med; 2012; 58(3):185-9. PubMed ID: 23023350
[TBL] [Abstract][Full Text] [Related]
14. Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India.
Maurya AK; Singh AK; Kant S; Umrao J; Kumar M; Kushwaha RA; Nag VL; Dhole TN
Indian J Med Microbiol; 2013; 31(3):230-6. PubMed ID: 23883707
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of reasons of the MDR M. tuberculosis strains dissemination by analysis of the rifampicin and/or isoniazid resistant isolates].
Sivkov AIu; Boldyrev AN; Azaev MSh; Bodnev SA; Medvedeva EV; Baranova OI; Ivlev-Dantau AP; Blinova LN; Pasechnikov AD; Tat'kov SI
Mol Gen Mikrobiol Virusol; 2006; (2):20-5. PubMed ID: 16755998
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
Silva C; Perdigão J; Jordão L; Portugal I
Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
[TBL] [Abstract][Full Text] [Related]
17. [Primary drug-resistance is the main cause of drug-resistant tuberculosis].
Mei J; Xue Z; Shen X; Shen GM; Gui XH; Shen M; Gao Q
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Feb; 29(2):75-8. PubMed ID: 16677445
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance and associated genetic mutations among patients with suspected MDR-TB in Uttar Pradesh, India.
Jain A; Singh PK; Chooramani G; Dixit P; Malhotra HS
Int J Tuberc Lung Dis; 2016 Jul; 20(7):870-5. PubMed ID: 27287637
[TBL] [Abstract][Full Text] [Related]
19. Modern and ancestral genotypes of Mycobacterium tuberculosis from Andhra Pradesh, India.
Thomas SK; Iravatham CC; Moni BH; Kumar A; Archana BV; Majid M; Priyadarshini Y; Rani PS; Valluri V; Hasnain SE; Ahmed N
PLoS One; 2011; 6(11):e27584. PubMed ID: 22114678
[TBL] [Abstract][Full Text] [Related]
20. The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.
Ezati N; Lukoye D; Wampande EM; Musisi K; Kasule GW; Cobelens FG; Kateete DP; Joloba ML
BMC Infect Dis; 2014 Dec; 14():703. PubMed ID: 25523472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
